Management of Unusual Cutaneous Malignancies: Atypical Fibroxanthoma, Malignant Fibrous Histiocytoma, Sebaceous Carcinoma, Extramammary Paget Disease

Dermatologic Clinics

Volumn 29, Issue 2, 2011, Pages 201-216

  Love, W Elliot ^a   Schmitt, Adam R ^b   Bordeaux, Jeremy S ^b  

^a METROHEALTH MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atypical fibroxanthoma; Extramammary Paget disease; Malignant fibrous histiocytoma; Sebaceous carcinoma; Skin cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; IMIQUIMOD; MITOMYCIN C; VINCRISTINE;

ATYPICAL FIBROXANTHOMA; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMOSURGERY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; EXCISION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LASER SURGERY; LOW DRUG DOSE; MALIGNANT FIBROUS HISTIOCYTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET SKIN DISEASE; PHOTODYNAMIC THERAPY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEBACEOUS CARCINOMA; SKIN CANCER; SKIN CARCINOGENESIS;

ADENOCARCINOMA, SEBACEOUS; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; MORBIDITY; PAGET DISEASE, EXTRAMAMMARY; SKIN NEOPLASMS; XANTHOMATOSIS;

EID: 79952747397     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2011.02.007     Document Type: Review

References (139)

1. Levan N.E., Hirsch P., Kwong M.Q. Pseudosarcomatous dermatofibroma. Arch Dermatol 1963, 88:908-912.
2. Helwig E.B. Atypical fibroxanthoma. Tex Med 1963, 59:664-667.
3. Fretzin D.F., Helwig E.B. Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer 1973, 31:1541-1552.
4. Jacobs D.S., Edwards W.D., Ye R.C. Metastatic atypical fibroxanthoma of skin. Cancer 1975, 35:457-463.
5. Jacoby W.D. Cryosurgical treatment of recurrent atypical fibroxanthoma of the skin. Preliminary report. Cutis 1978, 22:599-601.
6. Starink T.H., Hausman R., Van Delden L., et al. Atypical fibroxanthoma of the skin. Presentation of 5 cases and a review of the literature. Br J Dermatol 1977, 97:167-177.
7. Davis J.L., Randle H.W., Zalla M.J., et al. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. Dermatol Surg 1997, 23:105-110.
8. Limmer B.L., Clark D.P. Cutaneous micrographic surgery for atypical fibroxanthoma. Dermatol Surg 1997, 23:553-557. [discussion: 557-8].
9. Dei Tos A.P., Maestro R., Doglioni C., et al. Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol 1994, 145:11-17.
10. Hollstein M., Sidransky D., Vogelstein B., et al. p53 mutations in human cancers. Science 1991, 253:49-53.
11. Dilek F.H., Akpolat N., Metin A., et al. Atypical fibroxanthoma of the skin and the lower lip in xeroderma pigmentosum. Br J Dermatol 2000, 143:618-620.
12. Helwig E.B., May D. Atypical fibroxanthoma of the skin with metastasis. Cancer 1986, 57:368-376.
13. Farley R., Ratner D. Diagnosis and management of atypical fibroxanthoma. Skinmed 2006, 5:83-86.
14. Zalla M.J., Randle H.W., Brodland D.G., et al. Mohs surgery vs wide excision for atypical fibroxanthoma: follow-up. Dermatol Surg 1997, 23:1223-1224.
15. Kroe D.J., Pitcock J.A. Atypical fibroxanthoma of the skin. Report of ten cases. Am J Clin Pathol 1969, 51:487-492.
16. New D., Bahrami S., Malone J., et al. Atypical fibroxanthoma with regional lymph node metastasis: report of a case and review of the literature. Arch Dermatol 2010, 146:1399-1404.
17. Grosso M., Lentini M., Carrozza G., et al. Metastatic atypical fibroxanthoma of skin. Pathol Res Pract 1987, 182:443-447.
18. Rizzardi C., Angiero F., Melato M. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin. Anticancer Res 2003, 23:1847-1851.
19. Kemp J.D., Stenn K.S., Arons M., et al. Metastasizing atypical fibroxanthoma. Coexistence with chronic lymphocytic leukemia. Arch Dermatol 1978, 114:1533-1535.
20. Cooper J.Z., Newman S.R., Scott G.A., et al. Metastasizing atypical fibroxanthoma (cutaneous malignant histiocytoma): report of five cases. Dermatol Surg 2005, 31:221-225. [discussion: 225].
21. Sahn R.E., Lang P.G. Sentinel lymph node biopsy for high-risk nonmelanoma skin cancers. Dermatol Surg 2007, 33:786-792. [discussion: 792-3].
22. Kargi E., Güngör E., Verdi M., et al. Atypical fibroxanthoma and metastasis to the lung. Plast Reconstr Surg 2003, 111:1760-1762.
23. Giuffrida T.J., Kligora C.J., Goldstein G.D. Localized cutaneous metastases from an atypical fibroxanthoma. Dermatol Surg 2004, 30:1561-1564.
24. Dahl I. Atypical fibroxanthoma of the skin. A clinico-pathological study of 57 cases. Acta Pathol Microbiol Scand A 1976, 84:183-197.
25. Glavin F.L., Cornwell M.L. Atypical fibroxanthoma of the skin metastatic to a lung. Report of a case, features by conventional and electron microscopy, and a review of relevant literature. Am J Dermatopathol 1985, 7:57-63.
26. Sankar N.M., Pang K.S., Thiruchelvam T., et al. Metastasis from atypical fibroxanthoma of skin. Med J Aust 1998, 168:418-419.
27. Lum D.J., King A.R. Peritoneal metastases from an atypical fibroxanthoma. Am J Surg Pathol 2006, 30:1041-1046.
28. Bugatti L., Filosa G. Dermatoscopic features of cutaneous atypical fibroxanthoma: three cases. Clin Exp Dermatol 2009, 34:e898-e900.
29. Dettrick A., Strutton G. Atypical fibroxanthoma with perineural or intraneural invasion: report of two cases. J Cutan Pathol 2006, 33:318-322.
30. Patton A., Page R., Googe P.B., et al. Myxoid atypical fibroxanthoma: a previously undescribed variant. J Cutan Pathol 2009, 36:1177-1184.
31. Dzubow L.M. Mohs surgery report: spindle cell fibrohistiocytic tumors: classification and pathophysiology. J Dermatol Surg Oncol 1988, 14:490-495.
32. Murali R., Palfreeman S. Clear cell atypical fibroxanthoma-report of a case with review of the literature. J Cutan Pathol 2006, 33:343-348.
33. Orosz Z. Atypical fibroxanthoma with granular cells. Histopathology 1998, 33:88-89.
34. Wright N.A., Thomas C.G., Calame A., et al. Granular cell atypical fibroxanthoma: case report and review of the literature. J Cutan Pathol 2010, 37:380-385.
35. Diaz-Cascajo C., Weyers W., Borghi S. Pigmented atypical fibroxanthoma: a tumor that may be easily mistaken for malignant melanoma. Am J Dermatopathol 2003, 25:1-5.
36. Ferrara N., Baldi G., Di Marino M.P., et al. Atypical fibroxanthoma with osteoclast-like multinucleated giant cells. In Vivo 2000, 14:105-107.
37. Rudisaile S.N., Hurt M.A., Santa Cruz D.J. Granular cell atypical fibroxanthoma. J Cutan Pathol 2005, 32:314-317.
38. Luzar B., Calonje E. Cutaneous fibrohistiocytic tumours-an update. Histopathology 2010, 56:148-165.
39. Thosani M.K., Marghoob A., Chen C.S. Current progress of immunostains in Mohs micrographic surgery: a review. Dermatol Surg 2008, 34:1621-1636.
40. Ma C.K., Zarbo R.J., Gown A.M. Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans. Am J Clin Pathol 1992, 97:478-483.
41. Mirza B., Weedon D. Atypical fibroxanthoma: a clinicopathological study of 89 cases. Australas J Dermatol 2005, 46:235-238.
42. Mathew R.A., Schlauder S.M., Calder K.B., et al. CD117 immunoreactivity in atypical fibroxanthoma. Am J Dermatopathol 2008, 30:34-36.
43. Jensen K., Wilkinson B., Wines N., et al. Procollagen 1 expression in atypical fibroxanthoma and other tumors. J Cutan Pathol 2004, 31:57-61.
44. Lazova R., Moynes R., May D., et al. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer 1997, 79:2115-2124.
45. Luzar B., Calonje E. Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review. J Cutan Pathol 2010, 37:301-309.
46. Monteagudo C., Calduch L., Navarro S., et al. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Am J Clin Pathol 2002, 117:126-131.
47. Kanner W.A., Brill L.B., Patterson J.W., et al. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma. J Cutan Pathol 2010, 37:744-750.
48. Silvis N.G., Swanson P.E., Manivel J.C., et al. Spindle-cell and pleomorphic neoplasms of the skin. A clinicopathologic and immunohistochemical study of 30 cases, with emphasis on "atypical fibroxanthomas" Am J Dermatopathol 1988, 10:9-19.
49. Stadler F.J., Scott G.A., Brown M.D. Malignant fibrous tumors. Semin Cutan Med Surg 1998, 17:141-152.
50. Wollina U., Schönlebe J., Koch A., et al. Atypical fibroxanthoma: a series of 25 cases. J Eur Acad Dermatol Venereol 2010, 24:943-946.
51. Seavolt M., McCall M. Atypical fibroxanthoma: review of the literature and summary of 13 patients treated with mohs micrographic surgery. Dermatol Surg 2006, 32:435-441. [discussion: 439-41].
52. Leibovitch I., Huilgol S.C., Richards S., et al. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome. Dermatol Surg 2006, 32:1369-1374.
53. Huether M.J., Zitelli J.A., Brodland D.G. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 2001, 44:656-659.
54. Kauffman S.L., Stout A.P. Histiocytic tumors (fibrous xanthoma and histiocytoma) in children. Cancer 1961, 14:469-482.
55. O'Brien J.E., Stout A.P. Malignant fibrous xanthomas. Cancer 1964, 17:1445-1455.
56. Rouhani P., Fletcher C.D., Devesa S.S., et al. Cutaneous soft tissue sarcoma incidence patterns in the U.S: an analysis of 12,114 cases. Cancer 2008, 113:616-627.
57. Weiss S.W., Enzinger F.M. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978, 41:2250-2266.
58. Corpron C.A., Black C.T., Raney R.B., et al. Malignant fibrous histiocytoma in children. J Pediatr Surg 1996, 31:1080-1083.
59. Pezzi C.M., Rawlings M.S., Esgro J.J., et al. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 1992, 69:2098-2103.
60. Kearney M.M., Soule E.H., Ivins J.C. Malifnant fibrous histiocytoma: a retrospective study of 167 cases. Cancer 1980, 45:167-178.
61. Nascimento A.F., Raut C.P. Diagnosis and management of pleomorphic sarcomas (so-called "MFH") in adults. J Surg Oncol 2008, 97:330-339.
62. Gazziola C., Cordani N., Wasserman B., et al. Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts. Int J Oncol 2003, 23:343-351.
63. Foti C., Giannelli G., Berloco A., et al. Malignant fibrous histiocytoma arising on chronic osteomyelitis. J Eur Acad Dermatol Venereol 2002, 16:390-392.
64. Iglesias M.E., Vázquez Doval F.J., Idoate F., et al. Malignant fibrous histiocytoma at the site of total knee replacement. J Dermatol Surg Oncol 1994, 20:848-849.
65. Spirtos G., Qadri A., Phillips A.K. Malignant fibrous histiocytoma (MFH) arising within a cholecystectomy incision: a cause-and-effect relationship is possible between previous surgery and the development of a malignant fibrous histiocytoma within the operative site. J Surg Oncol 1988, 38:267-270.
66. Farber J.N., Koh H.K. Malignant fibrous histiocytoma arising from discoid lupus erythematosus. Arch Dermatol 1988, 124:114-116.
67. Yamamura T., Aozasa K., Honda T., et al. Malignant fibrous histiocytoma developing in a burn scar. Br J Dermatol 1984, 110:725-730.
68. Berth-Jones J., Graham-Brown R.A., Fletcher A., et al. Malignant fibrous histiocytoma: a new complication of chronic venous ulceration. BMJ 1989, 298:230-231.
69. Inoshita T., Youngberg G.A. Malignant fibrous histiocytoma arising in previous surgical sites. Report of two cases. Cancer 1984, 53:176-183.
70. Fanburg-Smith J.C., Spiro I.J., Katapuram S.V., et al. Infiltrative subcutaneous malignant fibrous histiocytoma: a comparative study with deep malignant fibrous histiocytoma and an observation of biologic behavior. Ann Diagn Pathol 1999, 3:1-10.
71. Headington J.T., Niederhuber J.E., Repola D.A. Primary malignant fibrous histiocytoma of skin. J Cutan Pathol 1978, 5:329-338.
72. Pettinato G., Manivel J.C., De Rosa G., et al. Angiomatoid malignant fibrous histiocytoma: cytologic, immunohistochemical, ultrastructural, and flow cytometric study of 20 cases. Mod Pathol 1990, 3:479-487.
73. Marcet S. Atypical fibroxanthoma/malignant fibrous histiocytoma. Dermatol Ther 2008, 21:424-427.
74. Sakamoto A., Oda Y., Itakura E., et al. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma. Mod Pathol 2001, 14:581-588.
75. Sakamoto A., Oda Y., Itakura E., et al. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma. Hum Pathol 2001, 32:1225-1231.
76. Worrell J.T., Ansari M.Q., Ansari S.J., et al. Atypical fibroxanthoma: DNA ploidy analysis of 14 cases with possible histogenetic implications. J Cutan Pathol 1993, 20:211-215.
77. Hashimoto H., Enjoji M. Recurrent malignant fibrous histiocytoma. A histologic analysis of 50 cases. Am J Surg Pathol 1981, 5:753-760.
78. Brown M.D., Swanson N.A. Treatment of malignant fibrous histiocytoma and atypical fibrous xanthomas with micrographic surgery. J Dermatol Surg Oncol 1989, 15:1287-1292.
79. Glenn J., Kinsella T., Glatstein E., et al. A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk. Cancer 1985, 55:1206-1214.
80. Gherlinzoni F., Bacci G., Picci P., et al. A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. J Clin Oncol 1986, 4:552-558.
81. Beach A., Severance A.O. Sebaceous gland carcinoma. Ann Surg 1942, 115:258-266.
82. Collins D.C. Carcinoma originating in sebaceous cysts. Can Med Assoc J 1936, 35:370-372.
83. Kass L.G., Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol 1989, 33:477-490.
84. Zürcher M., Hintschich C.R., Garner A., et al. Sebaceous carcinoma of the eyelid: a clinicopathological study. Br J Ophthalmol 1998, 82:1049-1055.
85. Shields J.A., Demirci H., Marr B.P., et al. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol 2005, 50:103-122.
86. Dasgupta T., Wilson L.D., Yu J.B. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer 2009, 115:158-165.
87. Dores G.M., Curtis R.E., Toro J.R., et al. Incidence of cutaneous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome. Cancer 2008, 113:3372-3381.
88. Nelson B.R., Hamlet K.R., Gillard M., et al. Sebaceous carcinoma. J Am Acad Dermatol 1995, 33:1-15.
89. Schwartz R.A., Torre D.P. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995, 33:90-104.
90. Shields J.A., Demirci H., Marr B.P., et al. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 2004, 111:2151-2157.
91. Callahan E.F., Appert D.L., Roenigk R.K., et al. Sebaceous carcinoma of the eyelid: a review of 14 cases. Dermatol Surg 2004, 30:1164-1168.
92. Dim-Jamora K.C., Perone J.B. Management of cutaneous tumors with mohs micrographic surgery. Semin Plast Surg 2008, 22:247-256.
93. Duman D.G., Ceyhan B.B., Celikel T., et al. Extraorbital sebaceous carcinoma with rapidly developing visceral metastases. Dermatol Surg 2003, 29:987-989.
94. Rao N.A., Hidayat A.A., McLean I.W., et al. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol 1982, 13:113-122.
95. Shields C.L., Naseripour M., Shields J.A., et al. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma. Ophthalmology 2002, 109:2129-2133.
96. Spencer J.M., Nossa R., Tse D.T., et al. Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery. J Am Acad Dermatol 2001, 44:1004-1009.
97. Thomas C.J., Wood G.C., Marks V.J. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience. Dermatol Surg 2007, 33:333-339.
98. Yen M.T., Tse D.T., Wu X., et al. Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of two cases and review of the literature. Ophthal Plast Reconstr Surg 2000, 16:211-215.
99. Cook B.E., Bartley G.B. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology 2001, 108:2088-2098.
100. Lan M.C., Lan M.Y., Lin C.Z., et al. Sebaceous carcinoma of the eyelid with neck metastasis. Otolaryngol Head Neck Surg 2007, 136:670-671.
101. Martinelli P.T., Cohen P.R., Schulze K.E., et al. Sebaceous carcinoma. Skin cancer 2008, 240-250. McGraw-Hill, New York. K. Nouri (Ed.).
102. Buitrago W., Joseph A.K. Sebaceous carcinoma: the great masquerader: emerging concepts in diagnosis and treatment. Dermatol Ther 2008, 21:459-466.
103. Lazar A.J., Lyle S., Calonie E. Sebaceous neoplasia and Torre-Muir syndrome. Curr Diagn Pathol 2007, 13:301-319.
104. Higgins H.J., Voutsalath M., Holland J.M. Muir-Torre syndrome: a case report. J Clin Aesthet Dermatol 2009, 2:30-32.
105. Hybarger C.P. Cutaneous malignant neoplasms. Current diagnosis & treatment in otolaryngology-head & neck surgery 2004, 221-238. McGraw-Hill, New York. 1st edition. A.K. Lalwani (Ed.).
106. Wick M.R., Goellner J.R., Wolfe J.T., et al. Adnexal carcinomas of the skin: II. extraocular sebaceous carcinomas. Cancer 1985, 56:1163-1172.
107. Taylor R.S., Perone J.B., Kaddu S., et al. Appendage tumors and hamartomas of the skin. Fitzpatrick's dermatology in general medicine 2008, vol. 1:1068-1087. McGraw-Hill, New York. 7th edition. K. Wolff, L.A. Goldsmith, S.I. Katz (Eds.).
108. Folberg R. The eye. Pathologic basis of disease 2005, 1424-1425. Elsevier Saunders, Philadelphia. 7th edition. V. Kumar, A.K. Abbas, N. Fausto (Eds.).
109. Snow S.N., Larson P.O., Lucarelli M.J., et al. Sebaceous carcinoma of the eyelids treated by mohs micrographic surgery: report of nine cases with review of the literature. Dermatol Surg 2002, 28:623-631.
110. Berlin A.L., Amin S.P., Goldberg D.J. Extraocular sebaceous carcinoma treated with Mohs micrographic surgery: report of a case and review of literature. Dermatol Surg 2008, 34:254-257.
111. Reina R.S., Parry E. Aggressive extraocular sebaceous carcinoma in a 52-year-old man. Dermatol Surg 2006, 32:1283-1286.
112. Husain A., Blumenschein G., Esmaeli B. Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol 2008, 47:276-279.
113. Calhoun K.E., Giuliano A.E. Breast cancer. Berek & Novak's gynecology 2007, 1605-1631. Lippincott Williams & Wilkins, Philadelphia. 14th edition. J.S. Berek (Ed.).
114. Tannous Z. Paget's disease. Skin cancer 2008, 371-374. McGraw-Hill, New York. K. Nouri (Ed.).
115. Yang W.J., Kim D.S., Im Y.J., et al. Extramammary Paget's disease of penis and scrotum. Urology 2005, 65:972-975.
116. Parker L.P., Parker J.R., Bodurka-Bevers D., et al. Paget's disease of the vulva: pathology, pattern of involvement, and prognosis. Gynecol Oncol 2000, 77:183-189.
117. Addis I.B., Hatch K.D., Berek J.S. Intraepithelial disease of the cervix, vagina, and vulva. Berek & Novak's gynecology 2007, 561-600. Lippincott Williams & Wilkins, Philadelphia. 14th edition. J.S. Berek (Ed.).
118. Shepherd V., Davidson E.J., Davies-Humphreys J. Extramammary Paget's disease. BJOG 2005, 112:273-279.
119. Bunker C.B. Diseases and disorders of the male genitalia. Fitzpatrick's dermatology in general medicine 2008, vol. 1:654-675. McGraw-Hill, New York. 7th edition. K. Wolff, L.A. Goldsmith, S.I. Katz (Eds.).
120. Crum C.P. The female genital tract. Pathologic basis of disease 2005, 1068-1069. Elsevier Saunders, Philadelphia. 7th edition. V. Kumar, A.K. Abbas, N. Fausto (Eds.).
121. Landay M., Satmary W.A., Memarzadeh S., et al. Premalignant & malignant disorders of the vulva & vagina. Current diagnosis & treatment obstetrics & gynecology 2007, 819-832. McGraw-Hill, New York. 10th edition. A.H. DeCherney, T.M. Goodwin, L. Nathan (Eds.).
122. Neuhaus I.M., Grekin R.C. Mammary and extramammary Paget disease. Fitzpatrick's dermatology in general medicine 2008, vol. 1:1094-1098. McGraw-Hill, New York. 7th edition. K. Wolff, L.A. Goldsmith, S.I. Katz (Eds.).
123. Wolff K., Johnson R.A. Skin signs of systemic cancers. Fitzpatrick's color atlas & synopsis of clinical dermatology 2009, 486-503. McGraw-Hill, New York. 6th edition.
124. Ekwueme K.C., Zakhour H.D., Parr N.J. Extramammary Paget's disease of the penis: a case report and review of the literature. J Med Case Reports 2009, 3:4.
125. Fanning J., Lambert H.C., Hale T.M., et al. Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. Am J Obstet Gynecol 1999, 180:24-27.
126. Guerrieri M., Back M.F. Extramammary Paget's disease: role of radiation therapy. Australas Radiol 2002, 46:204-208.
127. Lloyd J., Flanagan A.M. Mammary and extramammary Paget's disease. J Clin Pathol 2000, 53:742-749.
128. Sitakalin C., Ackerman A.B. Mammary and extramammary Paget's disease. Am J Dermatopathol 1985, 7:335-340.
129. Berger T.G. Dermatologic disorders. Current medical diagnosis & treatment 2008, 85-140. McGraw-Hill, New York. 47th edition. S.J. McPhee, M.A. Papadakis, L.M. Tierney (Eds.).
130. Cole P., Heller L., Bullocks J., et al. The skin and subcutaneous tissue. Schwartz's principles of surgery 2010, 405-421. McGraw-Hill, New York. 9th edition. F.C. Brunicardi, D.K. Andersen, T.R. Billiar (Eds.).
131. Adams Hillard P.J. Benign diseases of the female reproductive tract. Berek & Novak's gynecology 2007, 431-504. Lippincott Williams & Wilkins, Philadelphia. 14th edition. J.S. Berek (Ed.).
132. O'Connor W.J., Lim K.K., Zalla M.J., et al. Comparison of Mohs micrographic surgery and wide excision for extramammary Paget's disease. Dermatol Surg 2003, 29:723-727.
133. Zollo J.D., Zeitouni N.C. The Roswell Park Cancer Institute experience with extramammary Paget's disease. Br J Dermatol 2000, 142:59-65.
134. Lau J., Kohler S. Keratin profile of intraepidermal cells in Paget's disease, extramammary disease, and pagetoid squamous cell carcinoma in situ. J Cutan Pathol 2003, 30:449-454.
135. Cohen P.R., Schulze K.E., Tschen J.A., et al. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review. South Med J 2006, 99:396-402.
136. Tsutsumida A., Yamamoto Y., Minakawa H., et al. Indications for lymph node dissection in the treatment of extramammary Paget's disease. Dermatol Surg 2003, 29:21-24.
137. Hendi A., Brodland D.G., Zitelli J. Extramammary Paget's disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol 2004, 51:767-773.
138. Coldiron B.M., Goldsmith B.A., Robinson J.K. Surgical treatment of extramammary Paget's disease: a report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision. Cancer 1991, 67:933-938.
139. Luk N.M., Yu K.H., Yeung W.K., et al. Extramammary Paget's disease: outcome of radiotherapy with curative intent. Clin Exp Dermatol 2003, 28:360-363.